National Cancer Institute (U.S.)

"National Cancer Institute (U.S.)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.

Descriptor ID	D054547
MeSH Number(s)	I01.409.418.750.600.650.496.150 N03.540.052.750.150 N03.540.348.500.500.600.650.496.150
Concept/Terms	National Cancer Institute (U.S.) National Cancer Institute (U.S.) NCI (US) National Cancer Institute

Below are MeSH descriptors whose meaning is more general than "National Cancer Institute (U.S.)".

Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Government [I01.409]
Government Agencies [I01.409.418]
United States Government Agencies [I01.409.418.750]
United States Dept. of Health and Human Services [I01.409.418.750.600]
United States Public Health Service [I01.409.418.750.600.650]
National Institutes of Health (U.S.) [I01.409.418.750.600.650.496]
National Cancer Institute (U.S.) [I01.409.418.750.600.650.496.150]
Health Care [N]
Health Care Economics and Organizations [N03]
Organizations [N03.540]
Academies and Institutes [N03.540.052]
National Institutes of Health (U.S.) [N03.540.052.750]
National Cancer Institute (U.S.) [N03.540.052.750.150]
Government [N03.540.348]
Federal Government [N03.540.348.500]
United States Government Agencies [N03.540.348.500.500]
United States Dept. of Health and Human Services [N03.540.348.500.500.600]
United States Public Health Service [N03.540.348.500.500.600.650]
National Institutes of Health (U.S.) [N03.540.348.500.500.600.650.496]
National Cancer Institute (U.S.) [N03.540.348.500.500.600.650.496.150]

Below are MeSH descriptors whose meaning is related to "National Cancer Institute (U.S.)".

Below are MeSH descriptors whose meaning is more specific than "National Cancer Institute (U.S.)".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "National Cancer Institute (U.S.)" by people in this website by year, and whether "National Cancer Institute (U.S.)" was a major or minor topic of these publications.

Bar chart showing 23 publications over 13 distinct years, with a maximum of 4 publications in 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	1	0	1
2008	0	1	1
2009	0	1	1
2011	0	1	1
2012	0	1	1
2013	1	2	3
2014	1	0	1
2015	1	3	4
2016	1	3	4
2017	0	1	1
2019	1	0	1
2021	0	1	1
2024	0	3	3

Below are the most recent publications written about "National Cancer Institute (U.S.)" by people in Profiles.

Thompson HS, Ashing KT, Barrett NJ, Baskin ML, Carter-Bawa L, Nolan TS, Odedina FT, Rhoads KF, Sheppard VB, Zeigler-Johnson C. The state of cancer-focused community outreach and engagement (COE): reflections of Black COE directors. J Natl Cancer Inst. 2024 10 01; 116(10):1549-1554.

View in: PubMed
Ashare RL, Worster B, Nugent SM, Smith DM, Morasco BJ, Leader AE, Case AA, Meghani SH. Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers. J Natl Cancer Inst Monogr. 2024 08 15; 2024(66):267-274.

View in: PubMed
Ellison GL, Helzlsouer KJ, Rosenfield SM, Kim Y, Ashare RL, Blaes AH, Cullen J, Doran N, Ebbert JO, Egan KM, Heffner JL, Lee RT, McClure EA, McDaniels-Davidson C, Meghani SH, Newcomb PA, Nugent S, Hernandez-Ortega N, Salz T, Vidot DC, Worster B, Zylla DM. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers. J Natl Cancer Inst Monogr. 2024 08 15; 2024(66):202-217.

View in: PubMed
Bi X, Beadle D, Xu A, Neff J, DeGregorio N, Odeh M, McNair C, Grosso D, Porcu P, Gergis U, Flomenberg N, Klumpp TR. Design and Implementation of a Multipurpose Information System for Hematopoietic Stem-Cell Transplantation on the Basis of the Biomedical Research Integrated Domain Group Model. JCO Clin Cancer Inform. 2021 10; 5:1076-1084.

View in: PubMed
Polak R, Reilly JM, Elson LE, Gallegos-Kearin VC, Bhatnagar S, Schneider JC, Silver JK. Nutrition Education Services Described on National Cancer Institute (NCI)-Designated Cancer Center Websites. J Cancer Educ. 2019 Oct; 34(5):860-864.

View in: PubMed
Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, Rogak LJ, Gatewood M, Reeve BB, Mendoza TR, O'Mara AM, Denicoff AM, Minasian LM, Bennett AV, Setser A, Schrag D, Roof K, Moore JK, Gergel T, Stephans K, Rimner A, DeNittis A, Bruner DW. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):409-418.

View in: PubMed
Al-Hallaq HA, Chmura SJ, Salama JK, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Robinson CG, Pisansky TM, Winter KA, White JR, Xiao Y, Matuszak MM. Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):155-163.

View in: PubMed
Koran ME, Lipnik AJ, Baker JC, Banovac F, Omary RA, Brown DB. Procedural Impact of a Dedicated Interventional Oncology Service Line in a National Cancer Institute Comprehensive Cancer Center. J Am Coll Radiol. 2016 Sep; 13(9):1145-50.

View in: PubMed
Al-Hallaq HA, Chmura S, Salama JK, Winter KA, Robinson CG, Pisansky TM, Borges V, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Timmerman RD, White JR, Xiao Y, Matuszak MM. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e291-e298.

View in: PubMed
Giaddui T, Yu J, Manfredi D, Linnemann N, Hunter J, O'Meara E, Galvin J, Bialecki B, Xiao Y. Structures' validation profiles in Transmission of Imaging and Data (TRIAD) for automated National Clinical Trials Network (NCTN) clinical trial digital data quality assurance. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):331-333.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement